Molecular model of cyclin-dependent kinase 5 complexed with roscovitine
Walter Filgueira de Azevedo1, Renato Tadeu Gaspar, Fernanda Canduri
1Departamento de Fi;sica, IBILCE, UNESP 15054-000, São José do Rio Preto, SP, Brazil. walterfa@df.ibile.unesp.br
Biochemical and Biophysical Research Communications
|October 10, 2002
Summary
A structural model of CDK5-roscovitine complex reveals roscovitine binds the ATP pocket. This finding aids in developing new inhibitors for cyclin-dependent kinases (CDKs) targeting CDK5.
Area of Science:
- Biochemistry
- Structural Biology
- Medicinal Chemistry
Background:
- Roscovitine is a potent inhibitor of cyclin-dependent kinases (CDKs) 1, 2, and 5.
- While the CDK2-roscovitine complex structure is known, no structural data exists for CDK5-inhibitor complexes.
- Understanding CDK5-inhibitor interactions is crucial for developing targeted therapies.
Purpose of the Study:
- To develop a structural model for the CDK5-roscovitine binary complex.
- To investigate the binding interaction of roscovitine within the CDK5 ATP-binding pocket.
- To correlate structural differences with inhibitory activity against CDKs.
Main Methods:
- Computational modeling was used to generate the structural model of the CDK5-roscovitine complex.
- Structural comparison between the modeled CDK5-roscovitine complex and the known CDK2-roscovitine complex.
- Analysis of roscovitine's binding mode within the ATP-binding pocket of CDK5.
Main Results:
- The structural model indicates strong binding of roscovitine to the ATP-binding pocket of CDK5.
- Structural comparisons highlight key differences between CDK5 and CDK2 that influence roscovitine inhibition.
- The model provides insights into the molecular basis for roscovitine's differential inhibition of CDK family members.
Conclusions:
- The developed structural model provides a basis for understanding CDK5 inhibition by roscovitine.
- This work opens avenues for designing novel inhibitor families targeting CDK5.
- Further exploration of adenine derivative substituents is warranted for improved CDK5 inhibitors.
Related Concept Videos
01:45Positive Regulator Molecules
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
01:18ATP Synthase: Structure
ATP synthase or ATPase is among the most conserved proteins found in bacteria, mammals, and plants. This enzyme can catalyze a forward reaction in response to the electrochemical gradient, producing ATP from ADP and inorganic phosphate. ATP synthase can also work in a reverse direction by hydrolyzing ATP and generating an electrochemical gradient. Different forms of ATP synthases have evolved special features to meet the specific demands of the cell. Based on their specific feature, ATP...
02:39Positive Regulator Molecules
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:15M-Cdk Drives Transition Into Mitosis
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
00:50Anaphase Promoting Complex
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...